Skip to main content
. 2019 Apr 2;9:5500. doi: 10.1038/s41598-019-41933-4

Table 1.

Demographics and clinical characteristics of the study population and the study results of their lung biopsies.

Characteristics Controls All ILD* CTD-related ILD Idiopathic ILD p-value (controls vs all ILD)
n patients 13 30 15 14
Female sex 62 47 67 29 0.37
Age, mean years (SD) 67.4 (13.7) 50.0 (11.2) 49.1 (10.7) 51.0 (12.6) <0.001
Smoking behaviour Never 10 44 50 36 0.16
Previous 70 48 50 46
Current 20 8 0 18
FVC, % of predicted 101 (90–105) 84 (67–88) 85 (69–89) 83 (64–85) <0.001
n biopsies 13 47 26 19
MDA, μmol/g lung tissue 91 (87–101) 101 (91–131) 105 (90–133) 101 (96–117) 0.044
COX/SDH-ratio 0.12 (0.11–0.18) 0.10 (0.04–0.13) 0.10 (0.04–0.13) 0.10 (0.04–0.12) <0.001
mtDNA, copies/pulmonary cell 315 (267–471) 419 (323–527) 367 (301–484) 434 (365–542) 0.088
COX2/COX4-ratio 2.18 (2.10–2.43) 0.64 (0.51–0.89) 0.62 (0.51–0.89) 0.72 (0.53–0.89) <0.001
common deletion, % of mtDNA molecules 0 (0–13) 17 (0–32) 21 (0–36) 15 (0–29) <0.001

Presented are either percent or median (interquartile range) if not otherwise specified.

COX2/COX4, cytochrome c-oxidase subunit 2 protein normalized for cytochrome c-oxidase subunit 4 protein; COX/SDH-ratio, cytochrome c-oxidase/ succinate dehydrogenase activity ratio; CTD, connective tissue disease; ILD, interstitial lung disease; MDA, malondialdehyde; mtDNA, mitochondrial DNA; FVC, forced vital capacity; SD, standard deviation.

*In one patient it is unknown if the patient suffered from a CTD-related ILD or an idiopathic IDL.